LiVeritas Biosciences

Harnessing Molecular Integrity for Early Informed Decision Making

Webinars

Antibody-derived Drug Candidates

April 6, 2022 LCGC Webinar with Bruker Daltonics

Phase Appropriate LC-MS Strategy for the Rapid Characterization of Bispecific Antibodies

Lieza Danan, Ph.D. Co-Founder and CEO, LiVeritas Biosciences, Inc

Watch now

Antibody-derived Drug Candidates

November 2, 2021 ASMS 2021 - Bruker’s Virtual Workshop Pharma/BioPharma

Accelerating Biologics Development with Ultra High-Resolution LC/MS

Na Parra, Ph.D. Co-Founder and EVP Technical Marketing & Project Management, LiVeritas Biosciences, Inc

Watch now